Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Margareta Behrendt"'
Autor:
Cláudia Correia, Qing-Dong Wang, Gunilla Linhardt, Leif G. Carlsson, Benjamin Ulfenborg, Anna Walentinsson, Katarina Rydén-Markinhutha, Margareta Behrendt, Johannes Wikström, Peter Sartipy, Karin Jennbacken, Jane Synnergren
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Objective: After myocardial infarction (MI), the non-infarcted left ventricle (LV) ensures appropriate contractile function of the heart. Metabolic disturbance in this region greatly exacerbates post-MI heart failure (HF) pathology. This study aimed
Externí odkaz:
https://doaj.org/article/714a4f95ddb94bc2881a700d82903f31
Autor:
Damilola D. Adingupu, Sven O. Göpel, Julia Grönros, Margareta Behrendt, Matus Sotak, Tasso Miliotis, Ulrika Dahlqvist, Li-Ming Gan, Ann-Cathrine Jönsson-Rylander
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-15 (2019)
Abstract Background Sodium-glucose cotransporter 2 inhibitors (SGLT2i) is the first class of anti-diabetes treatment that reduces mortality and risk for hospitalization due to heart failure. In clinical studies it has been shown that SGLT2i’s promo
Externí odkaz:
https://doaj.org/article/d8d21f00761e46e7a13409051bf1ea06
Autor:
Marianne G. Pouwer, Suvi E. Heinonen, Margareta Behrendt, Anne-Christine Andréasson, Arianne van Koppen, Aswin L. Menke, Elsbet J. Pieterman, Anita M. van den Hoek, J. Wouter Jukema, Brendan Leighton, Ann-Cathrine Jönsson-Rylander, Hans M. G. Princen
Publikováno v:
Journal of Diabetes Research, Vol 2019 (2019)
Background. There is a lack of predictive preclinical animal models combining atherosclerosis and type 2 diabetes. APOE∗3-Leiden (E3L) mice are a well-established model for diet-induced hyperlipidemia and atherosclerosis, and glucokinase+/− (GK+/
Externí odkaz:
https://doaj.org/article/fcb568a4dba0410dbde997fd34268ac7
Autor:
Damilola D. Adingupu, Suvi E. Heinonen, Anne-Christine Andréasson, Mikael Brusberg, Andrea Ahnmark, Margareta Behrendt, Brendan Leighton, Ann-Cathrine Jönsson-Rylander
Publikováno v:
Journal of Diabetes Research, Vol 2016 (2016)
Aim. Models combining diabetes and atherosclerosis are important in evaluating the cardiovascular (CV) effects and safety of antidiabetes drugs in the development of treatments targeting CV complications. Our aim was to evaluate if crossing the heter
Externí odkaz:
https://doaj.org/article/ecc3d17e5ed04a3f99edd95ddbcc466d
Autor:
Margareta Behrendt, Arianne van Koppen, Suvi E. Heinonen, Ann-Cathrine Jönsson-Rylander, Anne-Christine Andréasson, Aswin L. Menke, Hans M.G. Princen, Brendan Leighton, Marianne G. Pouwer, Anita M. van den Hoek, J. Wouter Jukema, Elsbet J. Pieterman
Publikováno v:
Journal of Diabetes Research. 2019:1-13
Background. There is a lack of predictive preclinical animal models combining atherosclerosis and type 2 diabetes. APOE∗3-Leiden (E3L) mice are a well-established model for diet-induced hyperlipidemia and atherosclerosis, and glucokinase+/− (GK+/
Autor:
Matúš Soták, Sven Göpel, Ann-Cathrine Jönsson-Rylander, Tasso Miliotis, Li-Ming Gan, Julia Grönros, Margareta Behrendt, Ulrika Dahlqvist, Damilola D. Adingupu
Publikováno v:
Cardiovascular Diabetology
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-15 (2019)
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-15 (2019)
Background Sodium-glucose cotransporter 2 inhibitors (SGLT2i) is the first class of anti-diabetes treatment that reduces mortality and risk for hospitalization due to heart failure. In clinical studies it has been shown that SGLT2i’s promote a gene
Autor:
Marianne G, Pouwer, Suvi E, Heinonen, Margareta, Behrendt, Anne-Christine, Andréasson, Arianne, van Koppen, Aswin L, Menke, Elsbet J, Pieterman, Anita M, van den Hoek, J Wouter, Jukema, Brendan, Leighton, Ann-Cathrine, Jönsson-Rylander, Hans M G, Princen
Publikováno v:
Journal of Diabetes Research
Background There is a lack of predictive preclinical animal models combining atherosclerosis and type 2 diabetes. APOE∗3-Leiden (E3L) mice are a well-established model for diet-induced hyperlipidemia and atherosclerosis, and glucokinase+/− (GK+/
Autor:
Dick Wågsäter, Bruno Igreja, Nuno Pires, Anders Hamsten, Emina Vorkapic, Laura Brion, Alejandro M. Bertorello, Margareta Behrendt, Johannes Wikström, Per Eriksson, Maria João Pinho, Patrício Soares-da-Silva
Publikováno v:
Circulation Research. 116:642-652
Rationale: In human genetic studies a single nucleotide polymorphism within the salt-inducible kinase 1 ( SIK1 ) gene was associated with hypertension. Lower SIK1 activity in vascular smooth muscle cells (VSMCs) leads to decreased sodium-potassium AT
Autor:
A. Lindblom, Tasso Miliotis, Margareta Behrendt, Julia Grönros, Matúš Soták, Ulrika Dahlqvist, Damilola D. Adingupu, Ann-Cathrine Jönsson-Rylander, Helena U. Westergren, Sven Göpel, M. El Hachmane, Li-Ming Gan
Publikováno v:
European Heart Journal. 38
Autor:
Arne Dikkers, Birgitta Rosengren, Thomas Gautier, Uwe J. F. Tietge, Eva Hurt-Camejo, Daniel J. Rader, Margareta Behrendt, David S. Grass
Publikováno v:
Arteriosclerosis thrombosis and vascular biology, 33(12), 2707-2714. LIPPINCOTT WILLIAMS & WILKINS
Objective— High circulating levels of group IIA secretory phospholipase A 2 (sPLA 2 -IIA) activity and mass are independent cardiovascular risk factors. Therefore, inhibition of sPLA 2 -IIA may be a target for the treatment of atherosclerotic cardi